Innoviva (INVA) FCF Margin (2011 - 2026)
Innoviva's (INVA) quarterly FCF Margin came in at 35.5% in Q1 2026, down 1935.0% YoY from 1.93% in Q1 2025, and down 25.45% on a QoQ basis from 47.62% in Q3 2025.
Innoviva (INVA) FCF Margin (2011 - 2026) Analysis & Trends
Innoviva (INVA) has 16 years of FCF Margin data on file, last reported at 35.5% in Q1 2026.
- Quarterly FCF Margin fell 1935.0% year-over-year to 35.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 44.38% (down 413.0% YoY) and the FY2025 annual result came in at 47.6%, down 493.0% from the prior year.
- FCF Margin eased to 35.5% in Q1 2026, from 47.62% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 4408.67% in Q1 2022 to a low of 35.5% in Q1 2026.
- A 5-year average of 842.44% and a median of 54.85% in 2025 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin tumbled 301988 bps — and 2024, when it jumped 9665 bps.
- Tracing INVA's FCF Margin over 5 years: stood at 72.61% in 2022, then plunged by 34 bps to 47.88% in 2023, then gained by 1 bps to 48.4% in 2024, then retreated by 2 bps to 47.62% in 2025, then dropped by 25 bps to 35.5% in 2026.
- The last three FCF Margin figures came in at 35.5% (Q1 2026), 47.62% (Q3 2025), and 43.95% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | 43.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.10% |
| Mar 31, 2026 | 35.50% |
| Sep 30, 2025 | 47.62% |
| Jun 30, 2025 | 43.95% |
| Mar 31, 2025 | 54.85% |
| Sep 30, 2024 | 48.40% |
| Jun 30, 2024 | 43.76% |
| Mar 31, 2024 | 1,485.45% |
| Sep 30, 2023 | 47.88% |
| Jun 30, 2023 | 1,350.62% |
| Mar 31, 2023 | 1,388.79% |
| Sep 30, 2022 | 72.61% |
| Jun 30, 2022 | 1,923.61% |
| Mar 31, 2022 | 4,408.67% |
| Sep 30, 2021 | 93.40% |
| Jun 30, 2021 | 3,090.36% |
| Mar 31, 2021 | 5,357.13% |
| Dec 31, 2020 | 16,920.63% |
| Sep 30, 2020 | 84.06% |
| Jun 30, 2020 | 101.07% |